Microbial, immunologic, and clinical studies have implicated Actinobacillus actinomycetemcomitans, a gram-negative bacterium, in the pathogenesis of juvenile and adult periodontitis (22) . A. actinomycetemcomitans elaborates several soluble extracellular virulence factors which include a collagenase (16) , a fibroblast inhibition factor (17) , epitheliotoxin (2), bone resorbing factors (15) , leukocyte migration inhibition factor (20) , and leukotoxin specific for human and primate polymorphonuclear neutrophils (19) .
Several lines of evidence suggest that A. actinomycetemcomitans is a significant periodontal pathogen. Patients infected with A. actinomycetemcomitans elaborate.a significant humoral immune response to the bacterium (7, 22) . A. actinomycetemcomitans has been recovered from within the diseased gingival tissue (4) , and recently, this laboratory has demonstrated that A. actinomycetemcomitans can invade epithelial cells in culture (12) .
Substantial effort is currently directed toward understanding the precise role each of these virulence factors plays in the pathogenesis of A. actinomycetemcomitans-mediated periodontal disease (18) . The molecular analysis of virulence factors of A. actinomycetemcomitans has been hampered by the lack of efficient systems for genetic manipulation. Protocols for DNA transformation, generalized transduction, transposon mutagenesis, and allelic exchange are all unavailable.
An electrotransformation system for A. pleuropneumoniae which uses pYG10, a 5.0-kb naturally occurring plasmid isolated from a multiply antibiotic-resistant strain of A. pleuropneumoniae 80-8141, does exist (8) . Since both A. * Corresponding author.
actinomycetemcomitans and this strain are in the same genus, pYGlO and the electroporation conditions established for A. pleuropneumoniae were used as starting points for this study.
In this report, we describe the development of a highly efficient transformation system for A. actinomycetemcomitans that is useful for a variety ofA. actinomycetemcomitans strains. A potential shuttle vector containing a small, naturally occurring, cryptic plasmid isolated from an A. actinomycetemcomitans strain was constructed. All plasmids utilized were stable in both Escherichia coli and A. actinomycetemcomitans. The availability of these plasmids and an efficient transformation system should facilitate the molecular analyses of A. actinomycetemcomitans virulence factors.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains used in these studies and their relevant characteristics are listed in Table 1 . A. actinomycetemcomitans strains were routinely grown in Trypticase soy broth (Difco Laboratories, Detroit, Mich.) containing 0.6% yeast extract (Difco) and 0.04% sodium bicarbonate (Sigma Chemical Co., St.
Louis, Mo.) (TSBYE broth) at 37°C in a GasPak containing a generator of 10% CO2 (BBL, Cockeysville, Md.). The antibiotics vancomycin and bacitracin (Sigma) were added to final concentrations of 5 and 75 jig/ml, respectively, unless otherwise indicated. Solid media were prepared by adding 1.5% Bacto-agar (Difco) to TSBYE. For long-term maintenance, A. actinomycetemcomitans strains were frozen at -70°C in TSBYE containing 100 ,ul of dimethyl sulfoxide per ml. E. coli strains were grown aerobically in YT broth (14) at 370C. Plasmids. The detailed restriction maps and construction of plasmids described in the text are described in detail elsewhere (9) . In brief, plasmid pVT736-1, a naturally occurring 1.9-kb A. actinomycetemcomitans plasmid isolated from A. actinomycetemcomitans VT736, did not code for any selectable antibiotic phenotype tested. Therefore, pVT736-1 was unsuitable for developing a transformation system in A. actinomycetemcomitans without further manipulation. To obtain a selectable marker, attempts were made to clone the plasmid on an E. coli vector. Hence, pVT736-1 and pUC19 were digested with KpnI, mixed, and treated with T4 DNA ligase. The ligation mixture was used to transform E. coli DH5a, and transformants were selected on YT agar containing ampicillin and 5-bromo-4-chloro-3-indolyl-f-D-galactopyranoside (X-Gal). Recombinant colonies were screened for the presence of pUC19 containing a 1.9-kb KpnI fragment insert. Two populations of recombinant plasmids represented by pDL279 and pDL280 were obtained; they contain pVT736-1 in opposite orientations.
Plasmid pDL281 was constructed by digesting plasmids pVT736-1 and pGEM7Zf(-) (obtained from Promega, Madison, Wis.) with XhoI and transforming the resulting ligation reaction into E. coli DH5a. Transformants were selected on YT agar containing ampicillin and X-Gal, and recombinant colonies were screened for the presence of pUC19 containing a 1.9-kb XhoI fragment insert. A single population of clones carrying pVT736-1 in one orientation was obtained.
Plasmid pYG10, a naturally occurring plasmid from A. pleuropneumoniae, coding for chloramphenicol resistance (Cm%), was obtained from Guy Lalonde (8) .
Plasmid isolation. Five-milliliter cultures of A. actinomycetemcomitans transformants were screened for the presence of plasmids by a modification of the procedure of Anderson and McKay (1) . Briefly, bacterial pellets were washed and resuspended in 6.7% sucrose-50 mM Tris HCl-10 mM EDTA, pH 8.0. Bacteria were incubated in the presence of lysozyme at 37°C for 20 min and lysed by the addition of sodium dodecyl sulfate. Nucleic acids precipitated by 2-propanol were washed twice with 70% ethanol and once in 99% ethanol and allowed to air dry. Plasmid DNA preparations were digested with restriction enzymes and analyzed on 0.8% Tris-borate-EDTA gels by using standard protocols (11) . Large-scale plasmid preparations were obtained from 500-ml cultures of A. actinomycetemcomitans transformants, using a modification of the Anderson and McKay procedure, as described above. Plasmids from E. coli transformants were isolated by the alkaline lysis method of Birnboim and Doly (3) and analyzed on agarose gels following restriction enzyme digestion. Large-scale plasmid preparations for use in transformation were isolated from 1-liter cultures and purified by cesium chloride density gradient centrifugation (11) .
Restriction enzyme analysis. All restriction enzymes were purchased from Life Technologies, Inc., Gaithersburg, Md., or Boehringer Mannheim Biochemicals, Indianapolis, Ind., and were used in accordance with the manufacturer's instructions. Restriction mapping of plasmids was carried out by using single and double enzyme digestions, and analysis was by electrophoresis on 0.8% Tris-borate-EDTA agarose gels.
Plasmid transformation. (i). A. actinomycetemcomitans transformation. On day 1, 0.1 ml of frozen A. actinomycetemcomitans stock was inoculated into 1.0 ml of TSBYE broth and grown overnight as described above. The next day, the culture was diluted 1:20 and grown overnight again. On day 3, the A. actinomycetemcomitans cultures were diluted with an equal volume of fresh broth and allowed to grow to early logarithmic phase (3 h). The density of the cultures was read at 600 nm, and the bacteria were harvested by centrifugation in a Sorvall RT 6000B refrigerated centrifuge for 15 min at 3,000 rpm. The pellets were washed twice in half-volumes of ice-cold electroporation buffer (EPB; 15% glycerol, 272 mM sucrose, 2.43 mM K2HPO4, 0.57 mM KH2PO4, pH 7.4) and resuspended in fresh EPB to obtain a final optical density (OD) of 6.0 at 600 nm. This concentrated bacterial suspension was incubated on ice for 10 min prior to high-voltage pulse. Plasmid DNA was ethanol precipitated and resuspended in water at a concentration of 10 ,ug/ml (unless otherwise indicated) for use in transformation experiments. Fifty microliters of the concentrated bacterial suspension was mixed with the plasmid DNA in sterile cuvettes (Bio-Rad, Richmond, Calif.) with an interelectrode distance of 0.2 cm. High-voltage pulses were delivered with a GenePulser (Bio-Rad) set at 2,500 V, 200 Ql, and 25 ,uF. Following electroporation, bacteria were immediately transferred into 1.0 ml of warm TSBYE broth without antibiotics, and the broth was incubated for a period of 5 h (two doublings), unless otherwise indicated, to allow for expression of the transformed phenotype. Dilutions of transformed cultures were plated on TSBYE plates containing chloramphenicol (5 ,ug/ml), ampicillin (100 ,ug/ml), or spectinomycin (50 ,ug/ml), and cultures were incubated for 48 h as described above. mine the optimal stage of growth for transformation. The highest transformation efficiencies were achieved when the bacteria were in the early logarithmic phase of growth (4 h) (Fig. 2) . The number of transformants fell rapidly after this period of time.
Effect of plasmid DNA concentration. The effect of varying plasmid DNA concentration on total number of transformants was assessed by electroporating aliquots of prepared bacterial samples with concentrations of DNA ranging from 0.1 to 10 ,ug/ml. A dose-response curve using different DNA concentrations is depicted in Fig. 3 (Fig. 4) . The system appears to saturate at an OD of 6.0. The results show approximately a 10-fold increase in the number of transformants with increasing bacterial density from an OD of 1 to 6.
Effect of pH of EPB. The pH of the EPB has been demonstrated to affect the transformation efficiency in several systems (6) . Since the pH of our standard EPB could not be adjusted without affecting the ionic strength, we tested EPB at pH 7.4 with and without the addition of phosphates. Transformation efficiencies were comparable with both buffers (data not shown), suggesting that phosphates were not required for transformation. A series of EPB without phosphates with pHs of 4 to 8 were prepared, and bacterial cultures were resuspended in these buffers and transformed under identical conditions. An acidic pH was more favorable for transformation than a neutral pH (Fig. 5) . At pH 5.5, the number of transformants recovered was twofold higher than that at pH 7.4. Thus, the transformation system appears quite sensitive over a significant pH range.
Effect of length of recovery time. Five hours was initially chosen for the recovery time as this time represents approximately two generations for A. actinomycetemcomitans and should allow for maximal expression of the antibiotic resistance marker on the plasmid. The optimal recovery period following electroporation was determined by varying the recovery time from 1 to 5 h (Fig. 6) 
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Hence, the effect on transformation efficiency of freezing competent cells was determined. Since EPB contains 15% glycerol, it was reasoned that cells could be prepared to this stage in the procedure and then quickly frozen in a dry ice-ethanol bath prior to storage at -70°C. The transforma-104-tion efficiencies of freshly prepared ceUs and frozen competent cells were comparable (data not shown). We have tested cells that have been frozen for up to 2 months and have not seen a loss in transformation efficiency. However, once the cells have been thawed, they cannot be refrozen without a 3,3 . , _._,_._,_._,_._,_.significant loss in competence. I.
8Statistical analysis. The mean and standard deviation used to describe the results were calculated from at least duplicate Bacterial density at 600 nm experiments, using the software package Lotus 1-2-3. transformants recovered was optimal at 3 h and gradually declined thereafter. CFU of the same samples plated on nonselective media were determined to ascertain whether this decline was due to a decrease in total bacterial numbers. The results shown in Fig. 5 indicate that the bacteria continued to grow for a period of 4 h prior to a decrease in CFU. The number of transformants decreased after 3 h, suggesting that cell death was not responsible for the decrease in the number of transformants observed at 4 h. The transformation of A. actinomycetemcomitans was accomplished by electroporation, and the protocol was standardized by using A. actinomycetemcomitans ATCC 29522 and the shuttle vector pDL282. In general, the electroporation protocols were based on methods available for A. pleuropneumoniae (8) , Campylobacterjejuni (13), and E. coli (5) . Observations on the growth and metabolic requirements for A. actinomycetemcomitans made in this laboratory significantly influenced the optimization of the electroporation protocol. Several factors were investigated to optimize the transformation protocol. We routinely obtained 105 transformants by using 2.5 jig of pDL282 DNA per ml. These data will be important for the construction of gene libraries and in isolating specific transformants occurring at low frequencies.
Additional factors that influenced electroporation efficiency included the density of the bacterial suspension, the pH of the EPB, and the duration of the recovery period following electroporation. As expected, more transformants were recovered by increasing the bacterial density used for electroporation. Saturation occurred at a bacterial density of 6.0 at 600 nm. The pH of the EPB was also a factor affecting electroporation; twice the number of transformants were recovered with EPB at pH 5.5 versus pH 7.4. The recovery period following the delivery of the electrical pulse also plays a role in transformation efficiency. The maximum number of transformants was recovered following 3 h of recovery. In contrast, the total number of viable bacteria in the culture increased for 4 h after electroporation. These data suggest that the transformants may lose their plasmid in the absence of selective pressure. Transformation efficiency with logarithmic-phase bacterial cultures suspended in EPB and frozen to -70°C was comparable to that obtained with fresh bacterial cultures.
The A. pleuropneumoniae plasmid pYGlO was able to transform several A. actinomycetemcomitans strains. This plasmid has been reported to transform A. pleuropneumoniae and E. coli (8) , suggesting that pYGlO is a broad-hostrange plasmid.
The role of E. coli and A. actinomycetemcomitans modification systems on transformation was examined by using the shuttle vectors pDL282 and pYG10. We routinely obtained equal numbers of A. actinomycetemcomitans or E. coli transformants (105 per ,ug of DNA) with pDL282 isolated from the heterologous strain. In the case of pYG10, plasmid DNA isolated from A. actinomycetemcomitans was more efficient at transforming both E. coli and A. actinomycetemcomitans, suggesting a role for an A. actinomycetemcomitans modification system. However, the modification system of A. actinomycetemcomitans does not limit transformation of E. coli with either pDL282 or pYG10. The structures of pDL282 and pYGlO isolated from A. actinomycetemcomitans and E. coli transformants were found to be intact by single and double restriction enzyme digestion, suggesting that the plasmids did not undergo any deletions or rearrangements following transformation. The structural stability of these plasmids is of significance in applying these plasmids for routine DNA manipulations in either A. actinomycetemcomitans or E. coli. Surprisingly, pDL282 isolated from A. actinomycetemcomitans transformed A. actinomycetemcomitans 10-fold less than pDL282 isolated from E. coli and transformed into E. coli. The reason for this result is unclear.
The convenience of using DNA obtained from an E. coli donor for high-efficiency transformation of A. actinomycetemcomitans will prove invaluable in utilizing the extensive tools of E. coli genetics for the analysis of A. actinomycetemcomitans genes. Our laboratories are investigating the amount of passenger DNA that can be cloned and stably maintained in pDL282. We are also adapting pDL282 as a potential transposon delivery vehicle. The availability of these genetic tools will accelerate a molecular understanding of A. actinomycetemcomitans virulence factors.
